GB0123664D0 - Histone deacetylase 9 - Google Patents

Histone deacetylase 9

Info

Publication number
GB0123664D0
GB0123664D0 GBGB0123664.5A GB0123664A GB0123664D0 GB 0123664 D0 GB0123664 D0 GB 0123664D0 GB 0123664 A GB0123664 A GB 0123664A GB 0123664 D0 GB0123664 D0 GB 0123664D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
hdac9
histone deacetylase
nucleic acid
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0123664.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research Royal Cancer Hospital
Original Assignee
Institute of Cancer Research Royal Cancer Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research Royal Cancer Hospital filed Critical Institute of Cancer Research Royal Cancer Hospital
Priority to GBGB0123664.5A priority Critical patent/GB0123664D0/en
Publication of GB0123664D0 publication Critical patent/GB0123664D0/en
Priority to EP02765071A priority patent/EP1432792B1/en
Priority to US10/491,372 priority patent/US7291492B2/en
Priority to PCT/GB2002/004455 priority patent/WO2003029451A2/en
Priority to AT02765071T priority patent/ATE340257T1/de
Priority to JP2003532668A priority patent/JP4383170B2/ja
Priority to DE60214867T priority patent/DE60214867T2/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0123664.5A 2001-10-02 2001-10-02 Histone deacetylase 9 Ceased GB0123664D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0123664.5A GB0123664D0 (en) 2001-10-02 2001-10-02 Histone deacetylase 9
EP02765071A EP1432792B1 (en) 2001-10-02 2002-10-02 Histone deacetylase 9
US10/491,372 US7291492B2 (en) 2001-10-02 2002-10-02 Histone deacetylase 9
PCT/GB2002/004455 WO2003029451A2 (en) 2001-10-02 2002-10-02 Histone deacetylase 9
AT02765071T ATE340257T1 (de) 2001-10-02 2002-10-02 Histonedeacetylase 9
JP2003532668A JP4383170B2 (ja) 2001-10-02 2002-10-02 ヒストン脱アセチル化酵素９
DE60214867T DE60214867T2 (de) 2001-10-02 2002-10-02 Histonedeacetylase 9

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0123664.5A GB0123664D0 (en) 2001-10-02 2001-10-02 Histone deacetylase 9

Publications (1)

Publication Number Publication Date
GB0123664D0 true GB0123664D0 (en) 2001-11-21

Family

ID=9923113

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0123664.5A Ceased GB0123664D0 (en) 2001-10-02 2001-10-02 Histone deacetylase 9

Country Status (7)

Country Link
US (1) US7291492B2 (enExample)
EP (1) EP1432792B1 (enExample)
JP (1) JP4383170B2 (enExample)
AT (1) ATE340257T1 (enExample)
DE (1) DE60214867T2 (enExample)
GB (1) GB0123664D0 (enExample)
WO (1) WO2003029451A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532244A4 (en) 2001-06-14 2005-12-14 Bristol Myers Squibb Co NEW HISTONIC HUMAN DEACETYLASES
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1608628A2 (en) 2003-03-17 2005-12-28 Takeda San Diego, Inc. Histone deacetylase inhibitors
GB0321694D0 (en) * 2003-09-16 2003-10-15 Ark Therapeutics Ltd Genes and their therapeutic use
WO2006066133A2 (en) 2004-12-16 2006-06-22 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
WO2008039461A2 (en) * 2006-09-27 2008-04-03 Thinsilicon Corp. Back contact device for photovoltaic cells and method of manufacturing a back contact
WO2008150769A2 (en) * 2007-05-31 2008-12-11 Thinsilicon Corporation Photovoltaic device and method of manufacturing photovoltaic devices
RU2499599C2 (ru) 2007-09-28 2013-11-27 Интрексон Корпорейшн Конструкции терапевтического переключения генов и биореакторы для экспрессии биотерапевтических молекул и их применение
WO2010011700A2 (en) 2008-07-23 2010-01-28 The Brigham And Women's Hospital, Inc. Treatment of cancers characterized by chromosomal rearrangement of the nut gene
US20100282314A1 (en) * 2009-05-06 2010-11-11 Thinsilicion Corporation Photovoltaic cells and methods to enhance light trapping in semiconductor layer stacks
WO2010144421A2 (en) * 2009-06-10 2010-12-16 Thinsilicon Corporation Photovoltaic modules and methods of manufacturing photovoltaic modules having multiple semiconductor layer stacks
US20110114156A1 (en) * 2009-06-10 2011-05-19 Thinsilicon Corporation Photovoltaic modules having a built-in bypass diode and methods for manufacturing photovoltaic modules having a built-in bypass diode
US11441672B2 (en) * 2019-10-29 2022-09-13 Lokar, Inc. Adjustable shift lever mount

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393725A1 (en) * 1999-12-08 2001-06-14 Axys Pharmaceuticals, Inc. Histone deacetylase-8 proteins, nucleic acids, and methods of use
AU2002212350A1 (en) * 2000-10-31 2002-05-15 Bayer Aktiengesellschaft Regulation of human histone deacetylase
US20040077046A1 (en) 2000-12-20 2004-04-22 Dalia Cohen Histone deacetylase-related gene and protein
EP1409661A4 (en) 2001-06-14 2006-02-01 Sloan Kettering Inst Cancer HDAC9 POLYPEPTIDES, POLYNUCLEOTIDES AND USES THEREOF
EP1532244A4 (en) 2001-06-14 2005-12-14 Bristol Myers Squibb Co NEW HISTONIC HUMAN DEACETYLASES

Also Published As

Publication number Publication date
JP4383170B2 (ja) 2009-12-16
EP1432792A2 (en) 2004-06-30
DE60214867D1 (en) 2006-11-02
US7291492B2 (en) 2007-11-06
US20050130146A1 (en) 2005-06-16
JP2005503824A (ja) 2005-02-10
WO2003029451A3 (en) 2003-08-21
WO2003029451A2 (en) 2003-04-10
EP1432792B1 (en) 2006-09-20
ATE340257T1 (de) 2006-10-15
DE60214867T2 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
DE60214867D1 (en) Histonedeacetylase 9
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
WO1998022589A3 (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
WO2002014485A3 (en) Kallikrein gene
WO2000053776A3 (en) Human kallikrein-like genes
AUPP472398A0 (en) Protease susceptibility II
WO2002102316A3 (en) Histone deacetylase and methods of use thereof
DE69534471D1 (de) Peptide, die fähig sind die sh3-domäne des gap-proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2003014340A3 (en) Human histone deacetylase-related gene and protein hdac10
EP1383907A4 (en) ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEINS CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
AU2001288363A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1383871A4 (en) INSULATED HUMAN ENZYMATIC PROTEINS, NUCLEIC ACID MOLECULES ENCODING THESE PROTEINS, AND USES THEREOF
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
AU2002323612A1 (en) Novel clark protein and nucleic acid molecules and uses therefor
AU2002229060A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1383908A4 (en) ISOLATED HUMAN ENZYME PROTEINS, HUMAN ENZYME PROTEIN CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
EP1383877A4 (en) INSULATED HUMAN ENZYMATIC PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN ENZYMATIC PROTEINS, AND USES THEREOF
EP1395674A4 (en) ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEIN CODING NUCLEIC ACID MOLECULES AND USES THEREOF
AU2002257075A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002250346A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
WO2002063013A3 (en) Human acid phosphatase gene

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)